CMS’ interim rule states that Medicare will cover Covid-19 vaccines approved by the FDA, including those receiving emergency use authorization, in a reversal from its usual policy. The vaccine will be made available at no cost to Medicare beneficiaries.
Deferred care because of Covid-19 will lead to additional stress on the healthcare system in the very near future and here’s how insurers can manage it.
CVS Health plans to add rapid Covid-19 tests at 1,000 locations by the end of the year. The company has not specified which rapid tests it will offer.
GlaxoSmithKline saw a recovery in its vaccine sales in the third quarter after a big hit in the second as a result of the COVID-19 pandemic, putting it back on course to meet the lower end of earnings guidance for the year. The bounce-back wasn’t… Read More »Vaccine sales recover at GSK in Q3, but lockdown fears weigh on shares
The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million if the drug gets Emergency Use Authorisation (EUA) – despite the fact its effectiveness has been called into question. The initial agreement is for delivery over the… Read More »US buys Lilly COVID antibody, as effectiveness questions remain
La Casa Blanca y muchos estadounidenses han depositado sus esperanzas de derrotar a la pandemia de COVID-19 en una vacuna que se está desarrollando a la “velocidad de la luz”. Pero algunos científicos advierten que se espera demasiado, y demasiado pronto. “Todos piensan que COVID-19… Read More »Científicos advierten que se espera demasiado de una vacuna para COVID
The weeks of fear and uncertainty that Pam and Paul Alexander suffered as their adult daughter struggled against COVID-19 etched itself into the very roots of their hair, leaving behind bald patches by the time she left the hospital in early May. Tisha Holt had… Read More »For Each Critically Ill COVID Patient, a Family Is Suffering, Too
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. On the ‘Subject’ of Vaccine Trial Participants In the piece about the AstraZeneca vaccine trial subject who suffered severe spinal… Read More »Readers and Tweeters Shed Light on Vaccine Trials and Bias in Health Care
The White House and many Americans have pinned their hopes for defeating the COVID-19 pandemic on a vaccine being developed at “warp speed.” But some scientific experts warn they’re all expecting too much, too soon. “Everyone thinks COVID-19 will go away with a vaccine,” said… Read More »Scientists Warn Americans Are Expecting Too Much From a Vaccine
Handgun sales in California have risen to unprecedented levels during the COVID-19 pandemic, and experts say first-time buyers are driving the trend. The FBI conducted 462,000 background checks related to handgun purchases in California from March through September, an increase of 209,000, or 83%, from… Read More »As Anxieties Rise, Californians Buy Hundreds of Thousands More Guns
Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19
Shots: Molecular Partners to receive $65.8M as up front, including equity, and will receive $164.7M as an option payment for both MP0420 and MP0423 along with royalties on sales of therapies. Novartis to get an option to in-license global rights of MP0420 and MP0423 During… Read More »Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19
Why prioritizing health equity in the Covid-19 vaccine distribution is not just right, but necessary
Even though Covid-19 is distinct from any health crisis the country has previously faced, assessing U.S. public health strategies during past crises can provide insight into what has contributed to a more or less equitable response.
While the COVID-19 pandemic has challenged providers in significant ways, it unfortunately has also created new opportunities for a small handful of bad actors to take advantage of the outbreak to increase their reimbursement. Here’s how Cotiviti recently worked with MetroPlus Health Plan in New… Read More »Case study: Identifying potential fraud, waste, and abuse during the COVID-19 pandemic
Russia’s sovereign wealth fund has filed applications with the World Health Organization (WHO) that if approved could see the Sputnik V coronavirus vaccine backed for use in many countries around the world. The applications are for two WHO mechanisms, aimed at providing a route to… Read More »Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot
Eli Lilly says no more patients will be treated with its COVID-19 therapy bamlanivimab in a trial run by the US National Institute of Allergy and Infectious Diseases (NIAID), as results to date suggest it is unlikely to be effective. The ACTIV-3 study was comparing… Read More »NIAID drops Lilly antibody from ACTIV-3 COVID-19 trial
The post What’s in the air? Aerosol transmission drawing increased attention appeared first on Healthy Debate.
As COVID-19 took hold in March, U.S. doctors limited in-person appointments — and many patients avoided them — for fear of infection. The result was a huge increase in the volume of remote medical and behavioral health visits. Doctors, hospitals and mental health providers across… Read More »Telemedicine or In-Person Visit? Pros and Cons
With the ongoing pandemic of COVID-19, there is long wait for the vaccine to be approved. Even after the vaccine gets approved, there is no assurance of the complete eradication of virus. There will still be percentage of people who contract the illness. Therefore, it… Read More »Harnessing The Power of Real World Evidence to Fight COVID-19 Pandemic
A leader from the drug research and development company discusses unique problems faced by COVID-19 patients with prior cancer and autoimmune diagnoses.
By ANISH KOKA The most recent fiction dressed up as science about COVID comes to us courtesy of a viral Washington Post article. “How the Sturgis Motorcycle Rally may have spread coronavirus across the Upper Midwest” screams the headline. The charge made is that “within… Read More »Viruses on Motorcycles
The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.
Moderna is close to completing its phase 3 trial of COVID-19 vaccine candidate mRNA-1273 after completing recruitment of the 30,000 subjects in the trial. It’s also revealed that more than 25,000 of them have already received the second dose of the shot in the COVE… Read More »Moderna nears COVID-19 vaccine finish line as it wraps up study enrolment
Hopes that antibody-laden plasma taken from recovered COVID-19 patients could lessen the severity of the disease in others have taken a knock. The 464-subject PLACID trial – carried out in India – found that the use of so-called convalescent plasma was unable to prevent progression… Read More »Convalescent plasma misses the mark in phase 2 trial
US trials of AstraZeneca’s experimental COVID-19 vaccine AZD1222 have been cleared to restart by the FDA, several weeks after testing was suspended following a serious adverse reaction in one patient who received the shot. Separately, Johnson & Johnson has also announced it is resuming recruitment… Read More »AZ, J&J COVID-19 vaccine trials okay to restart in US
OAKLAND, Calif. — Amid fanfare in March, California officials celebrated the launch of a multimillion-dollar contract with Verily — Google’s health-focused sister company — that they said would vastly expand COVID testing among the state’s impoverished and underserved communities. But seven months later, San Francisco… Read More »Verily’s COVID Testing Program Halted in San Francisco and Oakland
COVID-19 cases are surging in rural places across the Mountain States and Midwest, and when it hits health care workers, ready reinforcements aren’t easy to find. In Montana, pandemic-induced staffing shortages have shuttered a clinic in the state’s capital, led a northwestern regional hospital to… Read More »COVID Spikes Exacerbate Health Worker Shortages in Rocky Mountains, Great Plains
Shots: The US FDA authorizes the restart of the P-III clinical study in the US following the resumption of trials in other countries in recent weeks. The FDA reviewed all safety data from studies globally and concluded it was safe to resume the trial A… Read More »AstraZeneca Resumes P-III Study of AZD1222 Against COVID-19 in the US
The app, developed by the Commons Project Foundation and the World Economic Forum, lets travelers share vaccination records, Covid-19 test results and health declarations.
There is a surging demand for pre-sterilized surgical technologies at healthcare facilities because of the desire to both curb risk factors associated with Covid-19 at hospitals and also reduce the possibility of bacterial co-infections.
Molly Wiese estaba perpleja. Sus padres y hermanos viven en el sur de California, y Wiese, abogada de 35 años, ha viajado cada Navidad desde que se mudó a Minnesota en 2007. Por la pandemia, Wiese pensó que esta vez sería más prudente quedarse. Pero… Read More »¿Viajas para el Día de Acción de Gracias? Deberás atravesar la barrera de COVID
To keep critical revenue flowing, hospitals and ambulatory surgery centers need to resume elective surgeries and procedures as quickly as possible and mobile apps can help by giving patients and staff vital information, provide advance symptom screening and help providers reduce elective procedure no-shows through… Read More »Technology can ease pandemic challenges faced by hospitals, ambulatory surgery centers
In the second and final debate of the 2020 presidential race, President Donald Trump and former Vice President Joe Biden sparred over Trump’s handling of the pandemic and Biden’s plan to reform health care. In stark contrast to the first debate, there was more policy… Read More »In Tamer Debate, Trump and Biden Clash (Again) on President’s Pandemic Response
COVID-19 cases are surging in rural places across the Mountain States and Midwest, and when it hits health care workers, ready reinforcements aren’t easy to find. In Montana, pandemic-induced staffing shortages have shuttered a clinic in the state’s capital, led a northwestern regional hospital to… Read More »COVID Spikes Exacerbate Health Worker Shortages in Rocky Mountains, Great Plains
Gilead’s Veklury (remdesivir) has become the first COVID-19 drug approved in the US following a nod from the FDA. As an antiviral drug, remdesivir works to stop replication of SARS-CoV-2, the virus that causes COVID-19. Originally intended as a treatment for Ebola virus, remdesivir made… Read More »Gilead’s remdesivir finally gets US approval
Molly Wiese was truly stumped. Her parents and siblings live in Southern California, and Wiese, a 35-year-old lawyer, has returned home every Christmas since she moved to Minnesota in 2007. Because of the pandemic, Wiese thought it would be wiser to stay put for once.… Read More »Travel on Thanksgiving? Pass the COVID
KHN chief Washington correspondent Julie Rovner discussed the impact of the election and the upcoming Supreme Court challenge on the Affordable Care Act with New Hampshire Public Radio’s “The Exchange” and WNYC’s “The Brian Lehrer Show” on Wednesday. Rovner also spoke with Newsy’s “Morning Rush”… Read More »KHN on the Air This Week
When COVID-19 began making headlines in March, Charles Collins pulled out a protective face mask from the supply at the manufacturing company in Rockaway, New Jersey, where he was the shop foreman and put it on. The dozen or so other workers at the facility… Read More »Workers Fired, Penalized for Reporting COVID Safety Violations
A renewed interest in whether the BCG vaccine (for tuberculosis) could also have an application for COVID-19 has been on the rise, as evidenced by this recent Cell publication, the University of Exeter’s involvement in the BRACE Trial and ongoing general press coverage. Furthermore, the list of clinical trials focusing… Read More »BCG – COVID-19 Hackathon Challenge Now Extended Through End of Year
Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing data science to look beyond the hype and seek definitive clinical evidence. Today, the notion of ‘data science’ has permeated… Read More »Data hackathon analyses truth behind TB vaccine and COVID-19
Shots: The approval is based on three studies including P-lll ACTT-1 study assessing the efficacy and safety of a 10-day treatment course of Veklury vs PBO in 1063 hospitalized patients with confirmed SARS-CoV-2 infection and mild, moderate or severe COVID-19 receiving the treatment with SOC.… Read More »Gilead’s Veklury (remdesivir) Receives the US FDA’s Approval as the First Treatment for COVID-19
Landmark FDA approval of antiviral drug as 1st COVID-19 treatment comes amid conflicting efficacy data
The Food and Drug Administration approved Gilead’s antiviral drug as the first treatment for Covid-19 but just last week a WHO report showed that the drug appeared to have little to no effect on hospitalized patients.
Can’t see the audio player? Click here to listen on SoundCloud. For the first time in a long time, there is some good news about the coronavirus pandemic: Although cases continue to climb, fewer people seem to be dying. And there are fewer cases than expected… Read More »KHN’s ‘What the Health?’: A Little Good News and Some Bad on COVID-19
Shots: The companies will collaborate to develop, manufacture, and distribute AT-527 to combat COVID-19. If approved, Atea will be responsible for distributing the treatment option in the US, with the option to request Genentech’s support, and Roche will be responsible for distribution outside the US… Read More »Roche Collaborates with Atea Pharmaceuticals to Develop AT-527 for COVID-19
Shots: The company reported the positive findings of a pooled analysis of six ongoing clinical studies which includes P-IIb/IIIb LATTE-2, ATLAS, ATLAS-2M, FLAIR, POLAR, and CUSTOMIZE studies evaluating long-acting cabotegravir and rilpivirine regimen in 1,744 patients with HIV-1 infection across 16 countries The positive findings… Read More »ViiV Healthcare Present Results of Long-Acting Cabotegravir and Rilpivirine at IDWeeK 2020
Roche may not be the first company that comes to mind for a COVID-19 treatment, but the Swiss firm is taking a big swing at the market to rival Gilead’s remdesivir. The company has joined forces with Atea Pharmaceuticals to develop, manufacture and distribute Atea’s… Read More »Roche to co-develop remdesivir rival in partnership with Atea
If we really want to stem the spread of the coronavirus as winter looms and we wait for a vaccine, here’s an idea: The government should pay bars, many restaurants and event venues to close for some months. That may sound radical, but it makes… Read More »Analysis: Winter Is Coming for Bars. Here’s How to Save Them. And Us.
Facing a pandemic, record unemployment and unknown future costs for COVID-19 treatments, health insurers selling Affordable Care Act plans to individuals reacted by lowering rates in some areas and, overall, issuing only modest premium increases for 2021. “What’s been fascinating is that carriers in general… Read More »Even With ACA’s Fate in Flux, Open Enrollment Starts Soon. Here’s What’s New.
If Joe Biden wins the presidency in November, health is likely to play a high-profile role in his agenda. Just probably not in the way he or anyone else might have predicted. Barring something truly unforeseen, it’s fairly certain that on Jan. 20 the U.S.… Read More »Biden’s Big Health Agenda Won’t Be Easy to Achieve
Covid-19 has presented the possibility of reinventing healthcare delivery and reimbursement must support this
While there are encouraging signs of reimbursement falling in step with the move towards a more value-based healthcare system, what is needed now to further encourage healthcare innovators is to properly rationalize approval processes imposed by the FDA and CMS.
President Donald Trump has repeatedly claimed to have saved 2 million lives from COVID-19 through his actions to combat the disease. Recently, he made the assertion during the NBC News town hall on Oct. 15 that replaced the second presidential debate. “But we were expected… Read More »Trump Says He Saved 2 Million Lives From COVID. Really?
The disruption to biopharma and medtech businesses caused by Covid-19, such as product launch and clinical trial delays, has underscored the need for a more digital focused strategy.
In our latest article in the What HCPs Think series, CREATION.co’s Jamie Doggett analyses the social media activity of doctors to determine their views on how schools should operate during COVID-19. When and how schools should return was a big question for the UK during… Read More »What HCPs Think about schools reopening
AstraZeneca’s COVID-19 vaccine trial could be ready to resume this week in the US after a seven-week hiatus while the FDA completed its review of a serious illness, according to reports. Citing four sources, Reuters said that the FDA is about to allow the large-scale… Read More »AZ’s COVID-19 vaccine trial ready to resume – reports
Donella Pogue has trouble finding dentists in her rural area willing to accommodate her 21-year-old son, Justin, who is 6 feet, 8 inches tall, is on the autism spectrum and has difficulty sitting still when touched. And this summer, he had a cavity and his… Read More »Bridging the Miles — And the Pandemic — Teledentistry Makes Some Dentists Wince
In mid-March, Karla Monterroso flew home to Alameda, California, after a hiking trip in Utah’s Zion National Park. Four days later, she began to develop a bad, dry cough. Her lungs felt sticky. The fevers that persisted for the next nine weeks grew so high… Read More »‘All You Want Is to Be Believed’: The Impacts of Unconscious Bias in Health Care
Just 15 days ahead of the election, Montana Lt. Gov. Mike Cooney laid out his ideas on how he’d handle the COVID-19 pandemic if elected governor. Details were few, but the Democrat’s plan became one of only a handful being offered by candidates in the… Read More »Despite Pandemic Threat, Gubernatorial Hopefuls Avoid COVID Nitty-Gritty
Shots: The companies collaborate for fast-track development of DNP-019 against COVID-19 The collaboration will expand Samsung’s CDO capabilities to provide a full scope of its development services from cell line development, process development, to non-clinical and clinical material manufacturing Samsung has introduced its proprietary cell-line… Read More »Samsung Biologics Collaborates with Dinona to Develop DNP-019 for COVID-19
As hospital admissions rebound to near-normal levels, total admissions are still expected to be down 10.5% for the year, according to an analysis by the Epic Health Research Network and the Kaiser Family Foundation.
Cuando Terry Mutter se despertó con dolor de cabeza y músculos adoloridos, el levantador de pesas amateur lo atribuyó a un entrenamiento duro. Sin embargo, ese miércoles a la noche tuvo 101 grados de fiebre y estaba claramente enfermo. “Me sentía como si me hubiera… Read More »¿Pueden los pacientes de COVID tener el tratamiento de Trump? Está bien preguntar
The war of words between Donald Trump and his top infectious diseases expert Dr Anthony Fauci has intensified as the president’s handling of the coronavirus pandemic comes under increasing scrutiny. CNN reported that on a campaign call a “frustrated and at times foul-mouthed” Trump ranted… Read More »Trump launches tirade against NIAID chief Fauci as COVID-19 crisis escalates
Sarah Rickwood delves into IQVIA data to find out exactly how pharma’s HCP engagement has changed over COVID-19, and what the channel mix might look like after the pandemic. The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. With… Read More »Time to change the channel? The future for customer engagement models
Pfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at a facility in Belgium, ready for delivery if it clears phase 3 testing. The output of the plant in Puurs should allow the partners to have 100… Read More »Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approved
The UK government has signed a contract to develop a controversial COVID-19 human challenge trial, where participants will be deliberately infected in a controlled environment with coronavirus to test whether a vaccine is effective. Contract research organisation (CRO) hVIVO, a subsidiary of Open Orphan, has… Read More »UK government signs contract for COVID-19 challenge trial
When Terry Mutter woke up with a headache and sore muscles on a recent Wednesday, the competitive weightlifter chalked it up to a hard workout. By that evening, though, he had a fever of 101 degrees and was clearly ill. “I felt like I had… Read More »Can Ordinary COVID Patients Get the Trump Treatment? It’s OK to Ask
Starting in January, Medicare will pay $75 for tests that take longer than two days, and will only pay $100 per test to laboratories that process most of their Covid-19 tests in less than two days.
Regular fliers are used to long queues to clear security – but a rigorous COVID-19 testing regime could be added to pre-flight checks backed by a digital “health passport” to prove passengers are free from the coronavirus. The UK is the latest country to test… Read More »UK trials digital ‘health passport’ to help borders reopen
SACRAMENTO — A November ballot initiative to raise property taxes on big-business owners in California is drawing unconventional political support from health care power players and public health leaders. They see Proposition 15 as a potential savior for chronically underfunded local health departments struggling to… Read More »Health Care Groups Dive Into Property Tax Ballot Fight, Eyeing Public Health Money
With so many incredible advancements in technology in the healthcare space, it’s important to understand where exactly these developments have a measurable impact.
Al menos la mitad de los votantes prefiere el enfoque de la atención médica del ex vicepresidente Joe Biden al del presidente Donald Trump, lo que sugiere que la preocupación por reducir los costos y manejar la pandemia podría influir en el resultado de esta… Read More »Al sopesar los temas de salud, la mayoría de los votantes se inclinan hacia Biden
Pfizer said it will wait until after the US election to file its COVID-19 vaccine with the US regulator, as it waits for important safety data to become available. The vaccine is being developed by Pfizer and development partner BioNTech and will wait until late… Read More »Pfizer to wait until after election to file COVID-19 vaccine in US
Roche’s pharmaceutical revenues have been hit by falling sales in its pharma division in Q3 but a spike in demand for COVID-19 tests spared the Swiss company’s blushes. Sales of its “big three” cancer drugs were all down considerably in Q3 as cheaper biosimilars gained… Read More »COVID-19 tests prop up Roche as US biosimilars bite in Q3
Shots: The companies reported the preclinical results of MRT5500 demonstrating the potential of the vaccine in neutralizing the Abs against SARS-CoV-2. The two doses of MRT5500 induced neutralizing antibody levels significantly higher than those observed in COVID-19 patients The preclinical data support the advancement of… Read More »Sanofi and Translate Bio to Advance MRT5500 into Clinical Study Against COVID-19
Gilead’s Veklury (remdesivir) has failed to produce an effect on hospital stay and mortality in COVID-19 patients in a large global trial, casting doubt on previous supportive study findings. The results from the World Health Organization’s large Solidarity trial are yet to be peer reviewed… Read More »Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
In March, Sue Williams-Ward took a new job, with a $1-an-hour raise. The employer, a home health care agency called Together We Can, was paying a premium — $13 an hour — after it started losing aides when COVID-19 safety concerns mounted. Williams-Ward, a 68-year-old… Read More »Most Home Health Aides ‘Can’t Afford Not to Work’ — Even When Lacking PPE
Trombonist Jerrell Charleston loves the give-and-take of jazz, the creativity of riffing off other musicians. But as he looked toward his sophomore year at Indiana University, he feared that steps to avoid sharing the coronavirus would also keep students from sharing songs. “Me and a… Read More »Musicians Improvise Masks for Wind Instruments to Keep the Band Together
Sanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after reporting that it stimulated antibodies against SARS-CoV-2 in preclinical testing. The French drugmaker’s Sanofi Pasteur vaccines division says it is planning a phase 1/2 trial of the… Read More »Sanofi preps trials of second COVID-19 shot, as Russia approves another
At least half of voters prefer former Vice President Joe Biden’s approach to health care over President Donald Trump’s, suggesting voter concern about lowering costs and managing the pandemic could sway the outcome of this election, a new poll shows. The findings, from KFF’s monthly… Read More »Majority of Voters Tilt Toward Biden as Health Issues Weigh Heavily
With a new nominee as the Supreme Court prepares to hear a case that could determine the future of the Affordable Care Act, the health law’s future has been thrown into question. According to the Robert Wood Johnson Foundation, the number of uninsured could increase… Read More »Report: 21M people could lose insurance if ACA is overturned
On Monday, President Donald Trump claimed that the World Health Organization (WHO) “admitted” he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness. In a post on Twitter, Trump wrote: “The World Health Organization just admitted that… Read More »No, the WHO Didn’t Change Its Lockdown Stance or ‘Admit’ Trump Was Right
Can’t see the audio player? Click here to listen on SoundCloud. Republicans appear to be on track to confirm Judge Amy Coney Barrett to the Supreme Court before Election Day, cementing a 6-3 conservative majority on the high court regardless of what happens Nov. 3. Democrats,… Read More »KHN’s ‘What the Health?’: Democrats May Lose on SCOTUS, But Hope to Win on ACA
By MICHAEL MILLENSON When powerful politicians confront a life-threatening diagnosis, it can change policy priorities. In addition to President Trump and a slew of top aides, five U.S. senators and 15 members of the House of Representatives have now tested positive or been presumed positive… Read More »Will Trump, Congressional Infections Boost Innovations For Covid-19 Survivors?
Shots: The independent DSMB recommended pausing the enrollment of the ACTIV-3 clinical trial. The trial is evaluating Lilly’s bamlanivimab (LY-CoV555, 7000mg) + remdesivir as a treatment for COVID-19 in hospitalized patients, and is sponsored by the NIAID Lilly trusts the judgment & supports independent DSMB… Read More »Eli Lilly Pauses Enrollment in ACTIV-3 Clinical Trial Due to Safety Concerns
Shots: The P-II study will evaluate STI-5656 in ~400 patients hospitalized due to COVID-19 having mild, moderate, and severe symptoms. The P-II clinical trials of abivertinib now cleared to proceed in both Brazil and the US The dose to be tested is the same as… Read More »Sorrento to Initiate P-II Study of STI-5656 (abivertinib maleate) for COVID-19 in Brazil
An antibody cocktail from Regeneron has been approved by the FDA as the first treatment for Ebola, offering hope that a similar approach could be used to combat COVID-19. The FDA approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for treatment of infection caused by Zaire ebolavirus… Read More »Regeneron’s antibody cocktail approved by FDA for Ebola
In late March, shortly after New York state closed nonessential businesses and asked people to stay home, Ashley Laderer began waking each morning with a throbbing headache. “The pressure was so intense it felt like my head was going to explode,” recalled the 27-year-old freelance… Read More »Sleepless Nights, Hair Loss and Cracked Teeth: Pandemic Stress Takes Its Toll
Los Angeles County officials attribute a dramatic decline in COVID-19 death and case rates among Blacks and Latinos over the past two months to aggressive workplace health enforcement and the opening of tip lines to report violations. Now, officials intend to cement those gains by… Read More »COVID Crackdowns at Work Have Saved Black and Latino Lives, LA Officials Say
Google’s sister company launched a program in California and other states to help route patients to nearby coronavirus testing. Dr. Vivian Lee, president of health platforms for Verily, shared lessons learned from that effort and Verily’s work with schools and businesses.
San Diego-based diagnostics startup Cue Health won a $481 million from the Department of Health and Human Services and the Department of Defense to produce more coronavirus tests. The company received an emergency use authorization in June for its rapid molecular test.
Lone Tree, Colorado.- Darcy Velásquez, de 42 años, y su madre, Roberta Truax, caminaban recientemente por el centro comercial Park Meadows, 15 millas al sur del centro de Denver, buscando regalos de Navidad para los dos hijos de Velásquez, cuando vieron una tienda con un… Read More »Aunque preferiría cerrar, la cadena de tiendas COVID-19 Essentials se expande
There is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of a second infection has been confirmed in the US. It is the fifth confirmed reinfection worldwide after at least four other cases were confirmed in Belgium, the… Read More »Coronavirus re-infection case confirmed in the US
As per the experts, one of the key reasons for the failure of therapeutic candidates in clinical trials is the use of conventional 2-dimensional (2D) cell culture systems in early research studies. The 2D systems are severely limited in a number of aspects. For instance,… Read More »3D Cell Cultures: Rejuvenation amidst COVID-19
Medicare doesn’t currently cover drugs approved under emergency use designations. But CMS Administrator Seema Verma said the agency was coming up with a plan to make sure Medicare beneficiaries were covered once a coronavirus vaccine is developed.
Fear of COVID-19 Keeps Patients From Seeking Medical Care A new survey finds that fear of COVID-19 has kept people from seeking medical care, including people with chronic conditions. The Doctor Weighs In
In previous winters, anyone struck by a sore throat or fever might assume they had flu, and head to bed with a hot drink and some painkillers. This year, the looming specter of COVID-19 could prompt those with flu-like symptoms to seek medical care instead.… Read More »The benefits of online scheduling during a “twindemic”
The assurances come amid concerns that the Trump administration would brush aside scientific expertise in its push for a vaccine ahead of the election on Nov. 3.
Digital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. These therapeutics are designed to engage patients in personalized treatment or… Read More »Digital Therapeutics: Key Concepts and Regulations to Tackle COVID-19 Pandemic
Results from a survey titled “Coronavirus Impact and Recovery of the Small Businesses Economy“, which has collected responses from over 520,000 business owners in the US and Canada. Some general positive trends, but still over 20% of small business owners have concerns of their financial… Read More »COVID-19 impact on small businesses: October 2020 Update
Los gigantes farmacéuticos Regeneron y Gilead Sciences obtuvieron el tipo de publicidad que el dinero no puede comprar luego que el presidente Donald Trump tomara sus medicamentos experimentales para tratar su infección por coronavirus, y se declarara completamente recuperado después de dejar el hospital. “Fue… Read More »COVID-19: las farmacéuticas elogiadas por Trump mandan dinero a Biden
Shots: Regeneron has submitted a request to the US FDA seeking EUA for its REGN-COV2 investigational Ab regimen to treat COVID-19. If EUA is granted, the US govt. has committed to making REGN-COV2 available in the US at no cost and would be responsible for… Read More »Regeneron Seeks the US FDA’s EUA for REGN-COV2 Antibody Combination to Treat COVID-19
Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the US government. The findings came from additional safety and efficacy data harvested from the US National Institute… Read More »Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Regeneron has followed Eli Lilly in asking the FDA for emergency approval of its COVID-19 antibody therapy, shortly after the drug was thrust into the spotlight by being used to treat President Trump. The request for emergency use authorization (EUA) for REGN-COV2 comes amid a… Read More »Regeneron joins Lilly in seeking emergency OK for COVID-19 antibody
KHN reporter Victoria Knight discussed this week’s vice presidential debate with Newsy’s “Morning Rush” on Thursday. Click here to watch Knight on Newsy Read “In Debate, Pence and Harris Offer Conflicting Views of Nation’s Reality,” by the staffs of KHN and PolitiFact KHN chief Washington… Read More »KHN on the Air This Week
Pharmaceutical giants Regeneron and Gilead Sciences got the kind of publicity money can’t buy this week after President Donald Trump took their experimental drugs for his coronavirus infection, left the hospital and pronounced himself fully recovered. “It was, like, unbelievable. I felt good immediately,” Trump… Read More »As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him
The convergence of the coronavirus pandemic and election season has complicated this year’s voting for residents of nursing homes, assisted living facilities and other long-term care centers. Many seniors who need help to get or fill out their ballots may be stymied by shifting rules… Read More »Pandemic Erects Barriers for Prized Bloc of Voters in Nursing Homes, Senior Facilities
Shots: EC has approved an advance purchase agreement in which the Janssen will supply 200 M doses of thw COVID-19 vaccine candidate to EU member states following approval from regulators. Additionally, the EU member states have an option to secure up to 200M additional doses… Read More »J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine
The European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after signing a supply deal for up to 400 million doses of Johnson & Johnson’s experimental candidate. The agreement is the third for coronavirus vaccine supply for the… Read More »EU ramps up supply of COVID-19 vaccine, drugs
Lilly and Incyte’s Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time
Shots: The companies shared the additional efficacy and safety data of the ACTT-2 study demonstrating baricitinib + remdesivir reduced time to recovery and improved clinical outcomes for patients with COVID-19 infection compared with remdesivir as monothx The biggest benefits were observed in patients requiring supplemental… Read More »Lilly and Incyte’s Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time
Healthcare providers won’t have to start paying back Medicare advance loans until a year after they were issued. Under the original timeline, hospitals were supposed to start paying back the loans in August.
Can’t see the audio player? Click here to listen on SoundCloud. President Donald Trump’s COVID-19 diagnosis — and that of two dozen or more other officials in the White House and Capitol Hill — has scrambled an already confusing autumn. The president’s illness has thrown into… Read More »KHN’s ‘What the Health?’: Trump vs. COVID
While all hospitals and health systems will no doubt encounter revenue-specific challenges related to the pandemic, a solid foundation and targeted approach for improved collections can help speed up the road to recovery. In fact, it was Sanford Health’s unique approach to increasing patient collections… Read More »Success at a glance: improved collections, part two
The Trump administration’s pandemic response: decisive action that saved lives, or the greatest failure of any presidential administration? During Wednesday’s vice presidential debate, Vice President Mike Pence and the Democratic challenger, Sen. Kamala Harris of California, offered drastically different takes — from behind plexiglass screens… Read More »In Debate, Pence and Harris Offer Conflicting Views of Nation’s Reality
Eli Lilly has asked the FDA for an Emergency Use Authorization for its COVID-19 antibody therapy, after announcing new efficacy data from an ongoing trial. It’s been a big week for this class of therapies – Regeneron’s antibody cocktail was famously used to treat president… Read More »Lilly asks FDA for emergency clearance for COVID-19 antibody therapy
A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future. As part of a new series looking at how pharma has responded to the pandemic, Neale Belson, SVP… Read More »Pharma’s response to COVID: GSK
The UK has been leading research into the COVID-19 outbreak, according to the country’s pharma trade body, but there needs to be a strategy to restart trials into other diseases. The Association of the British Pharmaceutical Industry (ABPI) said that restarting research into diseases such… Read More »Government needs strategy to kick-start R&D after COVID, says pharma body
It took Carrie Wanamaker several days to connect the face she saw on GoFundMe with the young woman she had met a few years before. According to the fundraising site, Adeline Fagan, a 28-year-old resident OB-GYN, had developed a debilitating case of COVID-19 and was… Read More »Young Doctor Succumbs to COVID, One of the South’s Many Health Workers Lost
CALEXICO, Calif. — The message wasn’t lost on Daniel Gonzalez. Early in the pandemic, one of the first things Imperial County did to ward off the virus was close the public bathrooms and, later, public cooling centers. In this sprawling Southern California desert, where summer… Read More »Hard Lives Made Harder by COVID: Homeless Endure a ‘Slow-Moving Train Wreck’
Shots: Eli Lilly reports additional data on its SARS-CoV-2 neutralizing Ab programs including interim data on combination therapy in diagnosed patients with mild-to-mod. COVID-19 and plans to make therapies available to patients The new analysis P-II BLAZE-1 study assessing LY-CoV555 (2800mg) + LY-CoV016 (2800mg) vs… Read More »Eli Lilly Seeks the US FDA’s EUA for its COVID-19 Antibody Treatment
The FDA granted an emergency use authorization to an algorithm developed by Dascena to predict which Covid-19 patients might face unstable blood pressure or respiratory decline.
Within one day, President Donald Trump announced his COVID diagnosis and was admitted to Walter Reed National Military Medical Center for treatment. The flurry of events was stunning, confusing and triggered many questions. What was his prognosis? When was he last tested for COVID-19? What… Read More »Does the Federal Health Information Privacy Law Protect President Trump?
The company announced data on the combination of two antibodies against the SARS-CoV-2 virus, showing significant reductions in viral load compared with placebo. The company has applied for an EUA for LY-CoV555 and will seek an authorization for the combination of that drug with LY-CoV016… Read More »Lilly seeks emergency clearance for Covid-19 monoclonal antibodies on Phase II data
The guidance calls for a median two months’ worth of follow-up safety data from well-designed Phase III studies as a precondition for a vaccine receiving an EUA. The Wall Street Journal reported that the White House had backed down in its opposition to the guidance,… Read More »FDA issues Covid-19 vaccine guidance as White House reportedly relents
Supplies of swabs for coronavirus and other critical NHS tests for diseases like cancer, diabetes and heart disease have been threatened by a failure at a facility operated by Roche. The company said the problems – which also include other items like reagents and screening… Read More »Roche working “around the clock” to tackle UK test supply problems
Supplies of swabs for coronavirus and other critical NHS tests for diseases like cancer, diabetes and heart disease have been threatened by a failure at a facility operated by Roche. The company said the problems – which also include other items like reagents and screening… Read More »Roche working “around the clock” to tackle UK test supply problems
GlaxoSmithKline and partner Vir Biotechnology are to expand a trial of an experimental antibody to treat COVID-19, putting heat on Regeneron’s rival that has been famously used to treat president Donald Trump. GSK and Vir began trials of the antibody on early-stage COVID-19 patients in… Read More »GSK and Vir expand COVID-19 antibody trial after Trump’s treatment with Regeneron’s rival
The Affordable Care Act, facing its first test during a deep recession, is providing a refuge for some — but by no means all — people who have lost health coverage as the economy has been battered by the coronavirus pandemic. New studies, from both… Read More »Refuge in the Storm? ACA’s Role as Safety Net Is Tested by COVID Recession
Older adults are especially vulnerable physically during the coronavirus pandemic. But they’re also notably resilient psychologically, calling upon a lifetime of experience and perspective to help them through difficult times. New research calls attention to this little-remarked-upon resilience as well as significant challenges for older… Read More »Lifetime Experiences Help Older Adults Build Resilience to Pandemic Trauma
As trust in the Food and Drug Administration wavers, several states have vowed to conduct independent reviews of any COVID-19 vaccine the federal agency authorizes. But top health experts say such vetting may be misguided, even if it reflects a well-founded lack of confidence in… Read More »Distrusting Trump, States Plan to Vet COVID Vaccines Themselves. Bad Idea, Say Experts.
Cozbi Mazariegos stays in shape these days by running room to room inside her Marin City apartment to answer questions from her kids, ages 7, 10 and 12. They’re all working at home on laptops issued by their school, Bayside Martin Luther King Jr. Academy.… Read More »One School, Two Choices: A Study in Classroom vs. Distance Learning
The FDA may have been blocked from issuing stricter guidelines for emergency approval of COVID-19 vaccines by the Trump administration, but it has still managed to make its new approach public. The regulator published “advice” to vaccine developers as part of documentation prepared for a… Read More »FDA gives COVID-19 vaccine ‘advice’ after White House blocks guidance
Riding the Next Wave: Getting Ready for COVID-19 Spikes COVID-19 spikes are occurring all across the country. Here are some ways to get through the next wave healthy and psychologically strong. The Doctor Weighs In
Provider access to medical history is crucial for patients diagnosed with COVID-19, which often leads to worse outcomes for those with significant comorbidities. But due to lack of interoperability between healthcare IT systems, patient history can be cumbersome to obtain—and this can hamper a physician’s… Read More »Dr. Emad Rizk: why analytics-driven interoperability is vital in 2020 and beyond
While payers and policymakers took a more narrow-minded perspective on innovation value in 2020, the year 2021 will bring an increased focus on a treatment’s societal value, how innovation interacts with digital technologies, and whether new innovations are able to reduce existing health outcome inequalities.
Digital healthcare means using communications and information technologies in medicine to diagnose, predict, treat, and monitor diseases. It is also widely used for prognosis, rehabilitation, behavioral health, and public health. Indians have witnessed a surge of smartphone and internet use since the last decade. This… Read More »ViewPoints Article: Digital Healthcare in India – Current Trends & Future
Members of the House and Senate have seen the need to boost the national stockpile with PPE that is made in America. Failure to do so would only exacerbate the problems when our healthcare system is stretched thin.
Shots: Qiagen to launch the QIAprep& Viral RNA UM Kit, designed to simplify and accelerate PCR swab analysis and remove key testing bottlenecks for Covid-19 and other RNA viruses The kit combines a liquid-based sample preparation step completed in the only 2min. with real-time PCR… Read More »Qiagen to Launch Viral RNA Epidemiology Test for COVID-19 and Other RNA Viruses
Patient experiences are evolving. How can pharma keep up?By listening to the people who are navigating this new landscape everyday. Integrating personal experiences and patient-reported data, this one-day virtual event features real-time conversations between people living with chronic conditions and Health Union industry experts. Tune in to any… Read More »The COVID-19 Effect: How Pharma Can Adapt to the Evolving Patient Experience
The European Medicines Agency has begun a second “rolling review” of a potential coronavirus vaccine jointly developed by BioNTech and Pfizer, setting up a race with a rival from AstraZeneca and Oxford University. The announcement comes just days after the regulator said its CHMP scientific… Read More »Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jab
One of the biggest medical advancements of recent times is the invention of the cell isolation method. Also known as cell sorting or cell separation, the cell isolation method has rapidly become an integral component of modern biological and medical research. In this method, a… Read More »How is Cell Isolation Revolutionizing Medical Industry?
An Excel spreadsheet was behind IT glitch that caused thousands of positive COVID-19 tests to be omitted from the UK’s official records, according to press reports. The issue that left almost 16,000 positive results going unreported has been blamed on the way Public Health England… Read More »Excel spreadsheet blamed for UK’s COVID-19 test and trace woes
The post Forest Bathing and other ways to keep stress under control appeared first on Healthy Debate.
Breaking up parties, confiscating booze and answering noise complaints — being a resident adviser has always required a willingness to be the “bad guy” and uphold university policy despite the protests of friends and peers. Now there’s a new element to the job description: COVID… Read More »Campus Dorm Resident Assistants Adjust to a New Role: COVID Cop
As stores, restaurants, airlines and offices try to lure clients back, this is what they need to do to earn my business: Make me feel safe — no, make me be as safe as possible. As I’ve begun to explore old haunts, some are doing… Read More »Analysis: ‘Don’t Be Afraid of COVID’? Not Buying It, Unless Businesses Do Job Right
As the coronavirus pandemic broke out across the country, health care providers and scientists relied on the standard method for detecting respiratory viruses: sticking a long swab deep into the nose to get a sample. The obstacles to implementing such testing on a mass scale… Read More »Easier-to-Use Coronavirus Saliva Tests Start to Catch On
HHS will renew its contract with TeleTracking Technologies for another $10.2 million. Earlier this year, HHS controversially shifted Covid-19 data collection to the company from the Centers for Disease Control and Prevention, which would normally handle data collection.
While the White House and doctors at Walter Reed have sought to reassure the public that Trump’s condition is improving, he has received numerous drugs for Covid-19, including the steroid dexamethasone, which is typically administered only to those who are critically ill.
With the virus reaching the Oval Office, the presidential diagnosis is shining a spotlight on some of the drugs reportedly administered to the POTUS.
As European regulators begin a rolling review of AstraZeneca’s COVID-19 vaccine, the focus in the UK has shifted to the government’s plans to distribute any vaccine that is deemed to be a safe and effective way of preventing the disease. According to weekend press reports… Read More »Older people first to receive COVID-19 vaccine in UK, says government
The post COVID-19 testing failing vulnerable communities appeared first on Healthy Debate.
President Donald Trump makes no secret he would like a COVID-19 vaccine to be available before the election. But it’s doubtful that will happen and, even after a vaccine wins FDA approval, there would be a long wait before it’s time to declare victory over… Read More »5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’
Shots: The P-I/II study of AZD1222 has resumed in Japan following the discussion with the PMDA. Additionally, the company is in talks with the US FDA to facilitate review of the information needed to decide regarding the resumption of the US trial A standard review… Read More »AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan
The company said it was meeting real-time supply demands for Veklury (remdesivir) in the U.S. and anticipated meeting global demands for the drug worldwide. AmerisourceBergen will continue acting as sole U.S. distributor.
President Donald Trump’s COVID-19 diagnosis is raising fresh questions about the White House’s strategy for testing and containing the virus for a president whose cavalier attitude about the coronavirus has persisted since it landed on American shores. The president has said others are tested before… Read More »The Mysterious White House Testing Scheme That Did Not Protect Trump
El diagnóstico de COVID-19 del presidente Donald Trump está generando nuevas preguntas sobre la estrategia de la Casa Blanca para realizar pruebas y contener la propagación del virus, con un presidente que ha tenido una actitud arrogante desde que el coronavirus aterrizó en suelo estadounidense.… Read More »El sistema de pruebas para COVID de la Casa Blanca no protegió al presidente
Nils Hase, a retiree who lives in Tarpon Springs, Florida, is wearing a mask and loading his Home Depot haul into his car on a recent weekday afternoon. In the store, because Home Depot insists customers and staff across the country wear masks, most faces… Read More »Wear a Mask. If Only It Were That Simple.
European regulators have started a first ‘rolling review’ of a COVID-19 vaccine, which is being developed by AstraZeneca in collaboration with the University of Oxford. It’s an historic announcement, bringing hope that the vaccine could be approved in the near future, although the European Medicines… Read More »European regulators begin rolling review of AZ’s COVID-19 vaccine
New research shows that the COVID-19 pandemic is encouraging people to take their health into their own hands, and experts say this trend towards self-care could be a significant boon for healthcare systems – one the pharma industry should be encouraging. We often hear how… Read More »COVID-19 drives a new era of self-care
In a wide-ranging executive order, President Donald Trump this month outlined some of the efforts he has made to affect health care since taking office. One involved uninsured people and the current pandemic. The administration, Trump said, set up a program to provide them “access… Read More »Trump’s COVID Program for Uninsured People: It Exists, but Falls Short
In August, Robert Pettigrew was working a series of odd jobs. While washing the windows of a cellphone store he saw a sign, one that he believes the “good Lord” placed there for him. “Facing eviction?” the sign read. “You could be eligible for up… Read More »Evictions Damage Public Health. The CDC Aims to Curb Them ― For Now.
Thousands of minks at Utah fur farms have died because of the coronavirus in the past 10 days, forcing nine sites in three counties to quarantine, but the state veterinarian said people don’t appear to be at risk from the outbreak. The COVID-19 infections likely… Read More »Thousands of Minks Dead as COVID Outbreak Escalates on Utah Farms
The post A tale of two pandemic cities appeared first on Healthy Debate.
We have more data on the J&J/Janssen coronavirus vaccine, which those keeping score at home will remember is an adenovirus vector candidate. It uses an obscure member of that virus family (Ad26) that very few people have ever been exposed to, as opposed to the… Read More »J&J Vaccine Data
Reuters reported Wednesday that U.S. regulators would look at data from previous clinical trials that came from the same scientists who created the vaccine, AZD1222, which originated at the University of Oxford and is also known as ChAdOx1 nCoV-19.
Shots: Moderna reported the publication of the second interim analysis of the open-label P-I study of mRNA-1273 in the NEJM. The study evaluated a 2dose vaccination schedule of mRNA-1273 given 28 days apart in 40 adults across two dose levels (25/100µg) in two age cohorts… Read More »Moderna’s mRNA-1273 COVID-19 Vaccine Demonstrate Immune Responses in Older Adults
Moderna’s Covid-19 vaccine shows antibody, T-cell responses a month after second dose in interim Phase I data
The company published interim data from the Phase I study of mRNA-1273 in 40 older and elderly adults, showing responses comparable to those seen in younger adults. The vaccine is being tested in a 30,000-participant Phase III trial.
The company said that those who received the two-antibody cocktail REGN-COV2 showed a lower viral loads and faster alleviation of symptoms than those who received placebo.
In rearchitecting the system by training every care provider in every specialty, and enable lower-cost providers and communities, we will provide a new model of care where a physician isn’t the person who helps us when we’re sick — they help us be healthy.
Here’s a potentially important paper that’s out in Science and is getting a lot of attention. The wide variation in severity of coronavirus infection has been noted throughout the pandemic, and we already know about a few of the risk factors: age, of course, but… Read More »Interferon and the Coronavirus
Earlier this month, the Congressional Budget Office (CBO) gave an update to its federal budget projections between 2020 and 2030. As expected, things look grim for 2020. CBO projects a federal budget deficit of $3.3 trillion in 2020, more than triple the shortfall recorded in… Read More »CBO: COVID-19’s impact on the federal budget
We now have the official clinical trial designs for the three biggest and most advanced coronavirus vaccine trials: Moderna, Pfizer/BioNTech and Oxford/AstraZeneca. Now, as for you, J&J, Novavax, Merck, and all the others that are pushing into efficacy trials as fast as possible – don’t… Read More »The Vaccine Protocols
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it has nominated a clinical drug candidate for the treatment of COVID-19, thus further advancing its COVID-19 program closer… Read More »NanoViricides Nominates a Novel Candidate for COVID-19 Treatment
We’re past six months of nationwide social distancing and lockdowns, use these tips to be ready for when it’s over.
The development of single-use bioreactors started nearly 40 years ago in 1980s. It was around this time that the bio-processors began to use plastic film bags to culture cells, which were initially designed for food storage and culture media containment. Moreover, incremental evolution of the… Read More »Single-Use Bioreactors on Rescue for COVID-19 Research
The healthcare industry’s response to the COVID-19 pandemic would likely have benefitted from fully interoperable systems, particularly regarding contact tracing and the integration of public health data with clinical care. In a recent panel discussion with Healthcare IT Today, Cotiviti CEO Emad Rizk, M.D., discussed… Read More »Video: Cotiviti CEO Emad Rizk, M.D., on the current state of interoperability
We have a bit of human clinical data from the Eli Lilly/Abcellera collaboration to make a monoclonal antibody therapy against the coronavirus. A full paper is coming soon, the press release says, but for now it looks like this is all we have to go… Read More »Monoclonal Antibody Data
The post Cheering from afar: Study illustrates public’s concerns over contact with healthcare workers appeared first on Healthy Debate.
The post Be wary of ‘game-changers:’ Use drugs wisely and safely appeared first on Healthy Debate.
We’ve seen the scientific community come together time and again throughout the COVID-19 pandemic, and we’re thrilled to have been part of a hackathon bringing together data scientists, epidemiologists and partner organizations focusing on analysing the hypothesis of whether the tuberculosis (TB) vaccine – BCG… Read More »BCG-COVID 19 Hackathon: Task 1 winners announced, Task 2 – data scientists – we need you!
Figure 1. Classification of COVID-19 Disease States.Adapted from Sidiqi, H.K. and M.R. Mehra, COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. J Heart Lung Transplant, 2020.  (This piece was co-authored by Prof. Gordon Broderick, Clinical Systems Biology at Rochester General Hospital.) The thing… Read More »Modeling Coronavirus – Cytokine Storm
The post 2 billion vials. Public acceptance. The obstacles to vaccine delivery appeared first on Healthy Debate.
The post ‘We should be embarrassed:’ Lack of plan for students with special needs raises concerns appeared first on Healthy Debate.
The post COVID-19 vaccines in the making appeared first on Healthy Debate.
‘There was a lot of death and suffering’: How soldiers turned the tide in Ontario’s long-term care homes
The post ‘There was a lot of death and suffering’: How soldiers turned the tide in Ontario’s long-term care homes appeared first on Healthy Debate.
The post It took moms to hack the COVID quacks appeared first on Healthy Debate.
La temporada de influenza se verá diferente este año, ya que los Estados Unidos se enfrentan a una pandemia de coronavirus que ya ha matado a más de 176.000 personas. Muchos estadounidenses son reacios a ir al médico y los funcionarios de salud pública temen… Read More »COVID + Influenza: éste es un buen año para vacunarse, aconsejan expertos
COVID-19 is Bringing Data Privacy into the Spotlight – This is How Healthcare Companies Should Respond
By DAN LINTON Privacy concerns across the country continue to increase, and consumers expect their healthcare information to be private. Headline-making data sales, skepticism of Silicon Valley privacy practices, and COVID-19 contact tracing concerns compounded with a general lack of consumer awareness have continued to generate an… Read More »COVID-19 is Bringing Data Privacy into the Spotlight – This is How Healthcare Companies Should Respond
President Donald Trump accepted the Republican Party’s nomination for president in a 70-minute speech from the South Lawn of the White House on Thursday night. Speaking to a friendly crowd that didn’t appear to be observing social distancing conventions, and with few participants wearing masks,… Read More »Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims
The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. In The Medscape Professional Networks’ latest white paper, Healthcare’s New Normal: COVID Speeds Shift to Digital Communications, key opinion leaders and industry experts agree that in the… Read More »COVID-19’s lasting impact on digital communication in healthcare
Flu season will look different this year, as the country grapples with a coronavirus pandemic that has killed more than 172,000 people. Many Americans are reluctant to visit a doctor’s office and public health officials worry people will shy away from being immunized. Although sometimes… Read More »COVID + Influenza: This Is a Good Year to Get a Flu Shot, Experts Advise
As the smoke thickened near her home in Santa Cruz, California, last week, Amanda Smith kept asking herself the same questions: Should we leave? And where would we go? The wildfire evacuation zone, at the time, ended a few blocks from her house. But she… Read More »How to Weigh Evacuation Options With Both Wildfires and COVID at Your Door
New rules by the Center for Medicare and Medicaid Services would penalize hospitals and laboratories that report Covid-19 data. Hospitals would be required to report the number of confirmed or suspected Covid-19 patient, occupied beds, and availability of ventilators and other critical supplies.
Vice President Mike Pence portrayed his boss, President Donald Trump, as a leader who has reached out across the aisle to help during the coronavirus pandemic. “President Trump marshaled the full resources of the federal government and directed us to forge a seamless partnership with… Read More »Pence Praises Trump’s ‘Seamless’ COVID Response, Leaves Out His State Feuds
In accepting the Republican Party nomination Wednesday night, Vice President Mike Pence accurately recounted the history of Baltimore’s Fort McHenry, and how a failed British bombardment in 1814 helped inspire Francis Scott Key to write “The Star-Spangled Banner.” Pence’s claims about the Trump administration as well… Read More »Republican Convention, Day 3: Revisionist History
Shots: Singlomics to receive upfront and is eligible to receive regulatory & commercial milestones along with royalties on sales of products. BeiGene get an exclusive global right (Ex-China) to develop & commercialize its preclinical assets (DXP-593 and DXP-604), as well as for a series of… Read More »BeiGene Signs an Exclusive License Agreement with Singlomics for Neutralizing COVID-19 Antibodies
Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in the age groups most susceptible to COVID-19. An analysis of the latest data from a phase 1 trial showed that… Read More »Moderna’s COVID vaccine works in older people, according to new data
Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have struggled to access the capital they need to scale up and make their mark on the industry. The COVID-19 pandemic… Read More »COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts
The drug, AZD7442, is designed to potentially provide at least six months of protection from Covid-19. The trial, which is funded by federal defense and health authorities in the U.S., is enrolling up to 48 healthy volunteers in the U.K. AstraZeneca’s double-antibody approach is similar… Read More »AstraZeneca starts Phase I study of long-acting double-antibody cocktail for Covid-19
Shots: The US FDA has issued EUA for Abbott’s BinaxNOW COVID-19 Ag Card rapid test for the detection of COVID-19. The test will be available at $5 and can deliver results in 15mins. The test utilizes lateral flow technology and has demonstrated a sensitivity of… Read More »Abbott’s BinaxNOW COVID-19 Ag Card Receives the US FDA’s EUA to Detect SARS-CoV-2 Infection
Alnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic. Brendan joined Alnylam in 2016 as one of the company’s first Europe-based employees and… Read More »Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast
Shots: FDC has launched two variants of Favipiravir under the brand names PiFLU and Favenza to treat mild to moderate COVID-19 in India. The products will be available across the country Both the variant will be available at $0.74 (Rs. 55) /tablet. The DCGI had… Read More »FDC Launches Two Variants of Favipiravir for COVID-19 in India
Leslie Cutitta said yes, twice, when clinicians from Massachusetts General Hospital in Boston called asking whether she wanted them to take — and then continue — extreme measures to keep her husband, Frank Cutitta, alive. The first conversation, in late March, was about whether to… Read More »Another COVID Mystery: Patients Survive Ventilator, But Linger in a Coma
Dr. Reza Chowdhury didn’t charge copays when his patients were low on cash. He gave them his home phone number and answered their medical questions at all hours. Once, when Chowdhury’s daughter, Nikita Rahman, struck up a conversation with a New York taxi driver, it… Read More »They Cared for Some of New York’s Most Vulnerable Communities. Then 12 Died.
Shots: The Korean MFDS has approved Celltrion’s IND to initiate a P-I trial of CT-P59 in patients with COVID-19. The company has initiated the enrollment and is set to evaluate the safety, tolerability, efficacy, PK, and immunogenicity of CT-P59. The company anticipates the completion of… Read More »Celltrion Initiates P-I Study of CT-P59 Against COVID-19 in Korea
A report by Kaufman Hall showed that while hospitals’ operating margins improved in July, they were down 96% since the start of the year. Including funding allocated through the CARES Act. Without CARES Act funding, hospital margins were still down 28%.
Darlene Dobry, Strategic Advisor, Medical Devices and Pharmaceuticals As the COVID-19 pandemic continues to bring the world’s economies, healthcare systems, and communities to their knees, the Pharma industry appears to be the shining hope to help us return to a new normal. Could the industry’s… Read More »Is COVID the Rx for the Pharmaceutical Industry’s Reputation?
The Republican National Convention offered Americans a picture Tuesday night of a compassionate White House in action. But not a lot was said about the biggest health crisis in a century that has killed more than 170,000 people in this country. First lady Melania Trump… Read More »Republican Convention, Day 2: Pomp, the Pandemic and Planned Parenthood
Dealing with a Rare Eye Disease in the Midst of COVID19 After being diagnosed with a rare eye disease, a doctor learns the best treatment is immunosuppression-a risky choice in the midst of COVID19 The Doctor Weighs In
Study uses genomic data to trace Covid-19 ‘superspreader’ event linked to February Biogen exec meeting
The study, by researchers at Harvard, MIT, The Broad and other institutions, used genomic analysis of cases linked to the Biogen meeting, linking much of the community transmission in the Boston area to a European genetic variant of SARS-CoV-2 that first appeared at the meeting.
Jerome Antone said he is one of the lucky ones. After becoming ill with COVID-19, Antone was hospitalized only 65 miles away from his small Alabama town. He is the mayor of Georgiana — population 1,700. “It hit our rural community so rabid,” Antone said.… Read More »Prognosis for Rural Hospitals Worsens With Pandemic
It’s official, California: COVID-19 has left us sick with worry and increasingly despondent. And our youngest adults — ages 18 to 29 — are feeling it worst. Weekly surveys conducted by the U.S. Census Bureau from late April through late July offer a grim view… Read More »Feeling Anxious and Depressed? You’re Right at Home in California.
Cheryl and Corrina Thinn were almost joined at the hip. The sisters, both members of the Navajo Nation, shared an office at Arizona’s Tuba City Regional Health Care. Cheryl conducted reviews to make sure patients were receiving adequate care. Corrina was a social worker. Their… Read More »Two Navajo Sisters Who Were Inseparable Died of COVID Just Weeks Apart
The patients at Dr. Eric Daar’s hospital are at high risk for serious illness from COVID-19, and he’s determined to make sure they’re part of the effort to fight the disease. He also hopes they can protect themselves in the process. When Daar and his… Read More »LA Hospital Seeks Vaccine Trial Participants Among Its Own High-Risk Patients
More than 1,000 front-line health care workers reportedly have died of COVID-19, according to Lost on the Frontline, an ongoing investigation by The Guardian and KHN to track and memorialize every U.S. health care worker who dies from the coronavirus. Earlier this month, the organizations… Read More »Many People of Color, Immigrants Among 1,080 US Health Workers Lost to COVID
Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments. Friday 13th March 2020 – I am not a superstitious person in general, but I will never forget that particular… Read More »Time for a health innovation pact: rethinking the design and delivery of healthcare
The FDA commissioner took to Twitter Monday night to defend his performance at the agency, which came under sharp criticism amid accusations that the authorization of a plasma treatment for Covid-19 was politically motivated and that he stood by while President Trump unfairly maligned FDA… Read More »Stephen Hahn and the terrible, horrible, no good, very bad FDA weekend
By KIM BELLARD These are, no question, hard times, due to the COVID-19 pandemic. In the U.S., we’re closing in on 180,000 deaths in the U.S. Some 40 million workers lost their jobs, and over 30 million are still receiving unemployment benefits. Hundreds of thousands,… Read More »Thriving in COVID Times
The biotech company reached a deal with the European Commission to supply an initial 80 million doses, while European Union member states will have the option to purchase 80 million more.
Before the prime-time GOP showcase began, President Donald Trump took to the podium Monday afternoon and delivered an approximately one-hour campaign-style speech to delegates after he was officially renominated by the Republican Party as its candidate for president. His comments were wide-ranging, and our partners… Read More »Republican Convention, Day 1: A Campaign-Style Trump Speech and More
So let’s take a few minutes to think about what happens when the vaccine trials start to read out. I’m making the assumption that the data will be freely available in a timely manner (which means before any decisions are made), because the alternative to… Read More »Preparing For the Vaccine Results
The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infections. The phase 1 trial – funded by the US government – will take place in the UK… Read More »Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail
If you have declined to wear a face mask during the COVID-19 crisis, you might want to reconsider, as the smoke from over 300 wildfires chokes people across central and Northern California. But you are going to have to think a little more about what… Read More »Wildfires Provide Another Reason to Mask Up
Shots: The first participants have been dosed in a P-I trial of AZD7442 to assess safety, tolerability, and PK of the combination mAbs in up to 48 healthy participants aged 18-55 yrs. in the UK. The study is funded by DARPA If AZD7442 proves to… Read More »AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19
In a business driven by profit, vaccines have a problem. They’re not very profitable — at least not without government subsidies. Pharma companies favor expensive medicines that must be taken repeatedly and generate revenue for years or decades. Vaccines are often given only once or… Read More »Rather Than Give Away Its COVID Vaccine, Oxford Makes a Deal With Drugmaker
As some parts of America gingerly begin to open up after months of near-total lockdown, people have questions. Will it be safe to take a train? A plane? Visit the hair salon? An indoor restaurant? There are many knowable parameters in the equation: your health;… Read More »Analysis: You’ve Checked for Fever. Now, What’s Your Risk Tolerance?
While the emergency use authorization granted Sunday was not seen as scientifically unwarranted, it drew concerns from some experts that it could hinder enrollment in clinical trials, while the timing and circumstances of the FDA’s move fueled suspicions that political pressure – rather than science… Read More »FDA’s emergency authorization for convalescent plasma in Covid-19 sparks controversy
On the first night of the Democratic National Convention, New York Gov. Andrew Cuomo was among the first in a weeklong parade of speakers to issue scathing critiques of the Trump administration’s coronavirus response. Cuomo’s criticisms drew a quick reply in a tweet from Michael… Read More »Is Cuomo Directive to Blame for Nursing Home COVID Deaths, as US Official Claims?
I suppose that I’m going to have to say something about yesterday’s convalescent plasma announcement. First, the medical aspects: in my view, for what that’s worth, convalescent plasma is likely to be at least somewhat helpful to hospitalized coronavirus patients. I think that its safety… Read More »Convalescent Plasma: The Science and the Politics
By JESSICA DaMASSA, WTF HEALTH From his vantage point at the helm of one of healthcare’s biggest IT infrastructure companies, Change Healthcare’s President & CEO, Neil de Crescenzo, has an unrivaled perspective at how covid19 has impacted hospital systems and payers. His business builds the… Read More »Change Healthcare’s CEO on Payers, Providers & The New Healthcare Economy
Trump launches baseless attack on FDA; agency controversially authorizes plasma treatment for Covid-19
Over the weekend, Trump called the agency, without evidence, part of a “deep state” that was slow-walking vaccines and drugs for Covid-19. The next day, the agency authorized convalescent plasma despite having turned it down shortly before due to insufficient evidence.
Shots: The first healthy volunteer has been dosed in a P-I study of GRAd-COV2 against COVID-19 which is conducted by the Lazzaro Spallanzani National Institute for Infectious Diseases under the sponsorship of ReiThera The P-I study will evaluate the safety & immunogenicity of GRAd-COV2 in… Read More »ReiThera Reports First Patient Dosing with its COVID-19 Vaccine Candidate in Italy
The FDA has allowed a blood plasma treatment for COVID-19 to be administered under an Emergency Use license – but some have decried the move as a “political stunt” as president Trump accuses the agency of impeding progress on coronavirus therapies. The convalescent plasma treatment… Read More »COVID plasma treatment gets emergency license from FDA after Trump criticism
China has already granted emergency use authorisation to multiple COVID-19 vaccines developed by domestic drugmakers and started dosing key workers, according to local media reports. Zheng Zhongwei, head of China’s COVID-19 vaccine development task force, made the revelation on Chinese television, saying that the vaccines… Read More »Chinese starts vaccinating key workers against COVID-19; report
JACKSONVILLE, Fla. — On a sweltering July morning, Rose Wilson struggled to breathe as she sat in her bed, the light from her computer illuminating her face and the oxygen tubes in her nose. Wilson, a retiree who worked as a public health department nurse… Read More »Florida’s Cautionary Tale: How Gutting and Muzzling Public Health Fueled COVID Fire
As the coronavirus crisis lit up this spring, headlines about how the U.S. could innovate its way out of a pending ventilator shortage landed almost as hard and fast as the pandemic itself. The New Yorker featured “The MacGyvers Taking on the Ventilator Shortage,” an… Read More »Inside the Race to Build a Better $500 Emergency Ventilator
The Trump administration’s latest effort to use COVID-19 rapid tests — touted by one senior official as a “turning point” in arresting the coronavirus’s spread within nursing homes — is running into roadblocks likely to limit how widely they’ll be used. Federal officials are distributing… Read More »Trump Is Sending Fast, Cheap COVID Tests to Nursing Homes — But There’s a Hitch
If all goes according to plan, Penn State University students who opt for an on-campus experience this fall will start in-person classes on Aug. 24 under the banner of a “Mask Up or Pack Up” campaign. By returning to campus, students are agreeing to wear… Read More »One College’s Pop-Up COVID Test: Stop and ‘Smell the Roses’ (Or the Coffee)
The companies also said their Phase II/III study, slated to enroll about 30,000 participants, had already dosed more than 11,000.
In a survey of 730 parents, 31% of them plan to keep their child home if schools open for in-person instruction, according to a survey published in JAMA Pediatrics. Many schools are still developing plans for remote and in-person instruction.
After four Riverside Community Hospital employees contracted Covid-19, they and their families sued HCA for failing to provide adequate protections. The plaintiffs said they were not given adequate access to PPE, not warned when they might have been exposed to Covid-19, and were encouraged to… Read More »Lawsuit accuses HCA of failing to protect healthcare workers during pandemic
In a near-empty arena on the river in his hometown of Wilmington, Delaware, former Vice President Joe Biden accepted the Democratic nomination for president, promising hope over fear, fairness over privilege, love over hate. And, he said, “Facts over fiction.” Let’s see about that. Our… Read More »Democratic Convention, Night 4: ‘Facts Over Fiction’ in Biden’s Speech
New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandemic continues. Here we highlight the biggest R&D, market access and digital coronavirus news of the past week.… Read More »Coronavirus pharma news round-up 21/08/20
Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an early-stage trial. There are no vaccines approved for COVID-19 and governments across the… Read More »Pfizer/BioNTech say COVID-19 jab on track for approval by year-end
Yousuf El-Jayyousi, a junior engineering student at the University of Missouri, wanted guidance and reassurance that it would be safe to go back to school for the fall semester. He tuned into a pair of online town halls organized by the university hoping to find… Read More »Swab, Spit, Stay Home? College Coronavirus Testing Plans Are All Over the Map
From the early days of the U.S. coronavirus outbreak, states have wrestled with the best course of action for bars and nightclubs, which largely have their economic prospects tied to social gatherings in tight quarters. As the virus has pinched the industry’s lifeblood, bar owners… Read More »Deadly Mix: How Bars Are Fueling COVID-19 Outbreaks
The failure of California’s infectious disease monitoring system for a stretch of at least 20 days in July and August triggered potentially deadly fallout that continues to reverberate across the state. The fallout has been most severe in heavily populated counties, which rely primarily on… Read More »California’s Data Failures Stymie Efforts to Curb the Virus
Even as his state is a hotbed for COVID-19, Florida Gov. Ron DeSantis has been pushing schools to reopen so parents have the choice of sending children back to the classroom or keeping them home to learn virtually. The Republican governor has said children without… Read More »DeSantis Says COVID Is a Lower Risk for School-Aged Kids Than Flu
Shots: The companies have shared additional P-I safety and immunogenicity data from their ongoing US study of the BNT162b2 against SARS-CoV-2, which has advanced into P-II/III evaluation. Across all populations, BNT162b2 was well tolerated with mild to moderate fever in fewer than 20% of the… Read More »Pfizer and BioNTech Plan for Regulatory Review of its COVID-19 Vaccine in October 2020
An overview of various aspects of the supply chain that would be crucial in the production and distribution of COVID-19 Vaccine. Write to us at email@example.com if you want a PDF copy of this report. Over the past seven months, the global pandemic caused by… Read More »ViewPoints: COVID-19 Vaccine Distribution the Next Supply Chain Frontier